Wen Wen
文雯
Wen Wen is the founder and CEO of Huanyi Biology (焕一生物), an AI-powered systems immunology company. She first appears in 5Y Capital's coverage in late 2020, when the firm led her company's angel round alongside Xinyuan Capital . In 5Y Capital's framing, she sits among a cohort of founders applying computational methods to drug discovery—she shared a panel in 2022 with the founders of Xingkangyuan, Jitai Medicine, Chen'an Biology, and XtalPi, discussing progress in their respective fields . The corpus does not include biographical details beyond her role and this investor-affiliated context.
AI-generated — may contain errors, please verify.
Coverage
July: Seeking Vast Possibilities | 5Y News Monthly
The big news from last month.
五源资本·From Tech to Business: New Possibilities Brought by ITBT | 5Y Talk
We spoke with five entrepreneurs about their progress and breakthroughs.
五源资本·5Y Talk | Next-Gen Computing + Experimentation: The Birth of New Application Categories
Technology, Industry, and the Future.
五源资本·5Y News｜Vivace Therapeutics Announces Completion of Angel Round Raising Tens of Millions of RMB
Huanyi Bio announced the completion of an angel funding round of tens of millions of RMB, led by 5Y Capital.
五源资本·
